期刊文献+

CLN3基因在卵巢癌和子宫内膜癌中过表达的研究 被引量:1

Overexpression analysis of CLN3 gene in human ovarian and endometnal carcinoma
下载PDF
导出
摘要 目的 研究CLN3基因在卵巢癌和子宫内膜癌中的表达水平变化。方法 采用半定量RT-PCR方法和Western Blot方法检测卵巢癌和子宫内膜癌组织中CLN3基因表达水平变化。结果 发现CLN3在所有的卵巢癌和子宫内膜癌组织中 有不同程度的表达水平升高现象。结论CLN3基因表达水平升高可能与卵巢癌和子宫内膜癌的发生有关。 Objective To determine whether overexpression of CLN3 was involved in the tumorigenesis of ovarian and endometrial ca-cinoma. Methods 10 specimens of ovarian and 8 specimens of endometrial carcinoma were screened for CLN3 gene expression level by semi-quantitative RT-PCR and Western Blot method. Results Overexpression of CLN3 rnRNA and protein was found in all ovarian and endometrial tumor tissues as compared with normal tissues. Conclusions The overexpression of CLN3 may contribute to tumor development of ovarian and endometrial cancer.
出处 《解放军保健医学杂志》 2004年第1期32-34,共3页 Journal Of Health Care And Medicine in Chinese Pla
关键词 CLN3基因 卵巢癌 子宫内膜癌 基因表达 细胞凋亡 ovarian neoplasm endometrial neoplasm CLN3 gene
  • 相关文献

参考文献6

  • 1[1]The International Batten Disease Consortium.Isolation of a novel gene underlying Batten disease [J].Cell,1995,82:949-957
  • 2[2]Lane S,Jolly RD,Schmechel DE,et al.Apoptosis as the mechanism of neurodegeneration in Batten disease [J].J Neurochem,1996,63:671-683
  • 3[3]Puranam K,Guo WX,Qian WH,et al.CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide [J].Molec Genet Metab,1999,66:294-308
  • 4[4]Reed JC.Mechanism of apoptosis avoidance in cancer [J].Curr Opin Oncol,1999,11:68-75
  • 5[5]Orrenius S.Apoptosis:molecular mechanism and implications for human disease [J].J Intern Med,1995,237:529-536
  • 6[6]Svetlana N,Rylova A,Dixie A,et al.The CLN3 gene is a novel molecular target for cancer drug discovery [J].Cancer Research,2002,62:801-808

同被引文献24

  • 1毛东伟,赵怡璇,马宝璋,李守柔.反义CLN3协同三氧化二砷诱导卵巢癌A2780细胞株凋亡的研究[J].中华医学杂志,2005,85(16):1140-1142. 被引量:1
  • 2Favrot M,Coll JL,Louis N,et al.Cell death and cancer:replacemet of apoptotic genes and inactivation of death suppressor genes in therapy [J].Gene Ther,1998 ,5(5) :728-739.
  • 3Mao Q,Foster BJ,Xia H,et al.Membrane topology of CLN3,the protein underlying Batten disease [J].FEBS Lett,2003 ,541(1-3) :40-46.
  • 4Lee RL,Johnson KR,Lerner TJ.Isolation and chromosomal mapping of a mouse homolog of the Batten disease gene CLN3[J].Ge nomics,1996,35(3):617-619.
  • 5Kremmidiotis G,Lensink IL,Bilton RL,et al.The Batten disease gene product (CLN3p) is a Golgi integral membrane protein [J].Hum Mol Genet,1999,8(3):523-531.
  • 6Phillips SN,Benedict JW,Weimer JM,et al.CLN3,the protein associated with batten disease:Structure,function and localization[J].J Neurosci Res,2005,79(5) :573-583.
  • 7Persaud-Sawin DA,McNamara Jo 2nd,Rylova S,et al.A galactosylceramide binding domain is involved in trafficking of CLN3from golgi to rafts via recycling endosomes[J].Pediatr Res ,2004,56 (3) :449-463.
  • 8Jarvela I,Lehtovirta M,Tikkanen R,et al.Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL) [J].Hum Mol Genet,1999,8(6):1091-1098.
  • 9Luiro K,Kopra O,Lehtovirta M,et al.CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles:new clues to Batten disease [J].Hum Mol Genet,2001,10 (19):2123-2131.
  • 10Orrenius S.Apoptosis:molecular mechanism and implications for human disease [J].J Int Med,1995,237(5) :529-536.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部